Vitamin D3 for Life

Live Enlightened

Article

Vitamin D, Skin Barrier Function and Keratinocyte Maintenance: Study Summary

Previous related pageVitamin D, Skin Barrier Function and Keratinocyte Maintenance: Full Evidence ReviewNext related pageVitamin D, Tissue Ageing and Senescence Markers: Full Evidence Review
Study at a glance

How were vitamin D signals and the skin barrier studied in animals?

Mouse and rat experiments tested different parts of skin-barrier function. One applied calcitriol, the active vitamin D hormone, to male mice with dermatitis, or skin inflammation, for four days. Another compared rats with no vitamin D receptor, rats with a receptor that bound vitamin D much less effectively, and normal rats.

Did active vitamin D applied to mouse skin improve the barrier?

The main treatment applied to the skin reduced water loss through the skin on later treatment days, improved dermatitis scores and restricted movement of a test substance within the skin. The method used to bring on dermatitis continued during treatment. Some defence and inflammatory signals changed, but others did not. A lower dose did not show the same benefit, and normal skin did not respond in the same way.

What happened when rats lacked a normal vitamin D receptor?

Rats without the receptor developed abnormal skin and hair. Rats retaining the altered receptor preserved several features but were not identical to normal rats. The water-loss difference between normal rats and rats without the receptor was clear only at 30 weeks among the ages examined. Some barrier-related genes were more active despite a poorer barrier, showing that gene activity cannot substitute for a test of how well the barrier worked.

Do these animal findings establish an eczema treatment for people?

Small samples, short treatment and reporting problems limit the mouse findings. The genetic changes affected the whole rat, so other body changes could influence the skin results. Separate human wound experiments examined local signals, not the same barrier treatment. These studies do not establish that oral vitamin D treats eczema, prevents skin infection or speeds wound healing.

Read the full article below ↓

Mouse and rat studies examined different parts of skin-barrier biology: topical active vitamin D in established dermatitis, and genetic alteration of VDR. Their results connect functional permeability measurements with keratinocyte maintenance, without establishing a human supplementation benefit. The full appraisal is Vitamin D, Skin Barrier Function and Keratinocyte Maintenance: Full Evidence Review.

Topical calcitriol changed selected dermatitis endpoints

Umehara and colleagues treated male NC/Nga mice for four days while the dermatitis challenge continued. The principal calcitriol regimen reduced water loss on later treatment days, improved dermatitis scores and better restricted a dermally applied tracer below the upper epidermis. These are distinct observations about Vitamin D and Barrier Immunity.

Immune responses were selective: Defb1 and Defb2 increased, while Camp was not induced; Il13 and Il33 decreased without an equivalent Il4 response. A lower-dose comparison did not show the same benefit, and normal skin did not respond identically. Small groups, short duration and an inconsistency in the printed primer table limit stronger mechanistic or safety claims.

Receptor loss and impaired ligand binding differed

Kise and colleagues compared wild-type rats, VDR-knockout rats and rats retaining a receptor with greatly reduced ligand binding. Knockout animals developed disrupted skin and hair phenotypes; the knock-in animals preserved several features but were not identical to wild type. The reported water-loss difference between wild type and knockout was significant only at thirty weeks among the examined ages.

Whole-skin RNA sequencing showed increased expression of some epidermal barrier-associated genes despite the poorer knockout barrier. Expression is therefore not a substitute for function. These whole-body models also retain systemic confounding; supplementary proteomics compared one female wild-type rat with one female knockout rat and was exploratory. The findings connect Vitamin D Receptors with Vitamin D and Cell Differentiation without quantifying the complete epidermal turnover cycle.

Conclusion

A separate human wound-signalling study supports local activation and selected antimicrobial responses. It should not be treated as a repeat of the mouse permeability experiments. The combined evidence concerns specific barrier, immune and maintenance mechanisms; it does not establish that oral vitamin D treats eczema, prevents skin infection or accelerates wound healing.

Sources and publication details

Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice. Umehara Y and colleagues. International Journal of Molecular Sciences. 2023;24(11):9347. DOI: 10.3390/ijms24119347. PMID: 37298299.

Ligand-Independent Vitamin D Receptor Actions Essential for Keratinocyte Homeostasis in the Skin. Kise S and colleagues. International Journal of Molecular Sciences. 2025;26(1):422. DOI: 10.3390/ijms26010422. PMID: 39796272.

Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. Schauber J and colleagues. Journal of Clinical Investigation. 2007;117:803 to 811. DOI: 10.1172/JCI30142. PMID: 17290304.

Related reading

Original sources

Source

Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice

Here, we investigated the effects of calcitriol, an active form of vitamin D3, on an NC/Nga mouse model of atopic dermatitis.

Publication details

Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice. Umehara Y and colleagues. International Journal of Molecular Sciences. 2023;24(11):9347. DOI: 10.3390/ijms24119347. PMID: 37298299.

Read more →